论文部分内容阅读
2.2 进口成药仍主要是亚洲国家和地区10大中成药进口国中(1995),三个国家是北美西欧国家(美、加、意)。而且可以看出(表8),美国、加拿大进口中成药一直在稳步增长,增长幅度较大,美国尤其是如此。西欧各国在进口中成药方面远不如美国、加拿大,西欧各国进口中成药总和尚不及美国。 但从另一方面看,进口中成药最多的而且比较稳定的仍主要是亚洲国家和地区。也就是说,应用中成药的仍主要是受中国文化影响深远的国家。除了表中列出的亚洲国家和地区之外,历年进口中成药较多的亚洲国家还有印尼、泰国、越南等,通常每年进口一二
2.2 Imported medicines are still mainly imported from 10 major Chinese and Western medicines in Asian countries (1995). The three countries are North American Western European countries (United States, Canada and Italy). As can be seen (Table 8), the imports of proprietary Chinese medicines from the United States and Canada have been steadily increasing and growing more rapidly, especially in the United States. Western European countries in the import of proprietary Chinese medicine is far less than the United States, Canada, Western Europe, the total import of proprietary Chinese medicines is less than the United States. However, on the other hand, the largest and more stable import of proprietary Chinese medicines is still mainly in Asian countries and regions. In other words, the application of proprietary Chinese medicine is still mainly influenced by the Chinese culture, far-reaching countries. In addition to the Asian countries and regions listed in the table, there are also many Asian countries that have imported more proprietary Chinese medicines over the years, such as Indonesia, Thailand and Vietnam,